Churchill Capital Corp XI is a special purpose acquisition company (SPAC) formed to raise capital in the public markets and later complete a business combination with one or more private operating companies. Until a merger closes, it holds IPO proceeds in trust and has essentially no commercial operations or product revenue. It is part of the Churchill Capital series of blank-check vehicles associated with financier Michael Klein.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q3 2025 | 0 | — | -0.1 | — |
| Q1 2026 | 0 | — | 3.2 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Aura Biosciences, Inc. (AURA), Nuvectis Pharma, Inc. (NVCT), Enovix Corporation (ENVX), Bowman Consulting Group Ltd. (BWMN), WhiteFiber, Inc. (WYFI), CytomX Therapeutics, Inc. (CTMX)